Cardiovascular effects of ajmaline

Area of Science:

• Pharmacology
• Cardiovascular Physiology

Background:

• Ajmaline is a rauwolfia derivative with known antiarrhythmic properties.
• Understanding its precise cardiovascular effects is crucial for therapeutic application.

Purpose of the Study:

• To define the cardiovascular effects of ajmaline.
• To investigate its impact on hemodynamic parameters, cardiac muscle contractility, and electrophysiology.

Main Methods:

• Hemodynamic studies in anesthetized and conscious dogs.
• Isolated papillary muscle studies.
• Electrophysiologic studies assessing conduction and automaticity.

Main Results:

• No significant hemodynamic changes at doses <= 2 mg/kg.
• No negative inotropic effects until 1 X 10(-4) concentration.
• Significant depression of intraventricular conduction, but no effect on AV nodal conduction or ventricular automaticity.
• Ajmaline abolished ventricular arrhythmias secondary to acute ischemia.

Conclusions:

• Ajmaline specifically depresses intraventricular conduction.
• The drug shows potential for treating re-entrant ventricular arrhythmias.
• Its effects on autonomic tone warrant further investigation.